AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD
The German pharmaceutical company Schering AG has received approval from the US Food and Drug Administration for Yasmin, its low-dose, monophasic oral contraceptive.
According to Schering Yasmin is the only birth control pill to contain the progestin drospirenone in addition to ethinylestradiol. The company claims that drospirenone can counteract oestrogen-based water retention in the body.
Berlex Laboratories Inc, the US subsidiary of Schering, …